Who can use Vyloy(zolbetuximab)?
Zolbetuximab is indicated for the treatment of Claudin 18.2 (CLDN18.2)-positive, unresectable advanced or recurrent gastric cancer.
Zolbetuximab is an injection (colorless vial): 100mg per vial.
zolbetuximab(Vyloy)
VYLOY is indicated for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or...
CATEGORY NAVIGATION
RELATED ARTICLES
Recommended Dosage and Administration of Zolbetuximab
Zolbetuximab (trade name: VYLOY) is a cytolytic antibody-drug targeting Claudin 18.2 (CLDN18.2). It was first...
Monday, September 1st, 2025, 11:39
1 / 1
1 in total
Departments
Contact Medical Consultant
Global Drug
Search
Clinical
recruitment
overseas
medical treatment
Remote
consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly
protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved